Zhang Z - Search Results

1

Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARgamma ligands (I).

Dong X, Zhang Z, Wen R, Shen J, Shen X, Jiang H. Dong X, et al. Among authors: zhang z. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5913-6. doi: 10.1016/j.bmcl.2006.06.093. Epub 2006 Sep 28. Bioorg Med Chem Lett. 2006. PMID: 17010604

2

Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.

Liu G, Zhang Z, Luo X, Shen J, Liu H, Shen X, Chen K, Jiang H. Liu G, et al. Among authors: zhang z. Bioorg Med Chem. 2004 Aug 1;12(15):4147-57. doi: 10.1016/j.bmc.2004.05.023. Bioorg Med Chem. 2004. PMID: 15246091

3

The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation.

Ye F, Zhang ZS, Luo HB, Shen JH, Chen KX, Shen X, Jiang HL. Ye F, et al. Chembiochem. 2006 Jan;7(1):74-82. doi: 10.1002/cbic.200500186. Chembiochem. 2006. PMID: 16317783

4

Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.

Zheng M, Zhang Z, Zhu W, Liu H, Luo X, Chen K, Jiang H. Zheng M, et al. Among authors: zhang z. Bioorg Med Chem. 2006 May 15;14(10):3428-37. doi: 10.1016/j.bmc.2005.12.062. Epub 2006 Feb 2. Bioorg Med Chem. 2006. PMID: 16458008

5

Binding investigation of human 5-lipoxygenase with its inhibitors by SPR technology correlating with molecular docking simulation.

Du L, Zhang Z, Luo X, Chen K, Shen X, Jiang H. Du L, et al. Among authors: zhang z. J Biochem. 2006 Apr;139(4):715-23. doi: 10.1093/jb/mvj084. J Biochem. 2006. PMID: 16672272

6

Towards discovering dual functional inhibitors against both wild type and K103N mutant HIV-1 reverse transcriptases: molecular docking and QSAR studies on 4,1-benzoxazepinone analogues.

Zhang Z, Zheng M, Du L, Shen J, Luo X, Zhu W, Jiang H. Zhang Z, et al. J Comput Aided Mol Des. 2006 May;20(5):281-93. doi: 10.1007/s10822-006-9050-6. Epub 2006 Aug 8. J Comput Aided Mol Des. 2006. PMID: 16897578

7

Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist.

Feng S, Yang M, Zhang Z, Wang Z, Hong D, Richter H, Benson GM, Bleicher K, Grether U, Martin RE, Plancher JM, Kuhn B, Rudolph MG, Chen L. Feng S, et al. Among authors: zhang z. Bioorg Med Chem Lett. 2009 May 1;19(9):2595-8. doi: 10.1016/j.bmcl.2009.03.008. Epub 2009 Mar 9. Bioorg Med Chem Lett. 2009. PMID: 19328688

8

Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction.

Zhang Z, Lin Z, Zhou Z, Shen HC, Yan SF, Mayweg AV, Xu Z, Qin N, Wong JC, Zhang Z, Rong Y, Fry DC, Hu T. Zhang Z, et al. ACS Med Chem Lett. 2014 Jul 14;5(9):993-8. doi: 10.1021/ml500160m. eCollection 2014 Sep 11. ACS Med Chem Lett. 2014. PMID: 25221655 Free PMC article.

9

3D-QSAR study of 20 (S)-camptothecin analogs.

Lu AJ, Zhang ZS, Zheng MY, Zou HJ, Luo XM, Jiang HL. Lu AJ, et al. Acta Pharmacol Sin. 2007 Feb;28(2):307-14. doi: 10.1111/j.1745-7254.2007.00477.x. Acta Pharmacol Sin. 2007. PMID: 17241535

10

Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy.

Wong JC, Guo L, Peng Z, Zhang W, Zhang N, Lai W, Zhang Z, Zhang C, Zhang X, Song S, Pan D, Xie C, Li J, Ning Z, Lu X, He Y, Chen L. Wong JC, et al. Among authors: zhang n, zhang c, zhang w, zhang z, zhang x. Bioorg Med Chem Lett. 2011 Jan 1;21(1):110-6. doi: 10.1016/j.bmcl.2010.11.063. Epub 2010 Nov 19. Bioorg Med Chem Lett. 2011. PMID: 21145737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111,050 results

Search Page

Filters